
|Videos|June 7, 2019
Dr. Pennell on Guidelines, Barriers, and Access to Molecular Testing in NSCLC
Author(s)Nathan A. Pennell, MD, PhD
Cancer Network spoke with Nathan A. Pennell, MD, PhD, of Cleveland Clinic at ASCO 2019 regarding current use of and barriers to molecular testing in NSCLC.
Advertisement
Cancer Network spoke with Nathan A. Pennell, MD, PhD, chair at Cleveland Clinic, at ASCO 2019 regarding guidelines, barriers, and access to molecular cancer in non-small-cell lung cancer during the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Topical Gel for Superficial Basal Cell Carcinoma
2
FDA Approves TLX101-Px for PET Imaging in Patients With Glioma
3
Debating CAR T-Cell Therapy Vs Bispecifics at First Relapse in Myeloma
4
FDA Extends Review of Zanzalintinib Combo in Pretreated Metastatic CRC
5























































